JP2014518071A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014518071A5 JP2014518071A5 JP2014516069A JP2014516069A JP2014518071A5 JP 2014518071 A5 JP2014518071 A5 JP 2014518071A5 JP 2014516069 A JP2014516069 A JP 2014516069A JP 2014516069 A JP2014516069 A JP 2014516069A JP 2014518071 A5 JP2014518071 A5 JP 2014518071A5
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- composition
- item
- polynucleotide
- genes listed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims description 52
- 210000001519 tissue Anatomy 0.000 claims description 46
- 239000000523 sample Substances 0.000 claims description 42
- 108091033319 polynucleotide Proteins 0.000 claims description 37
- 102000040430 polynucleotide Human genes 0.000 claims description 37
- 239000002157 polynucleotide Substances 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 29
- 235000020934 caloric restriction Nutrition 0.000 claims description 18
- 210000000593 adipose tissue white Anatomy 0.000 claims description 11
- 210000005003 heart tissue Anatomy 0.000 claims description 11
- 210000002027 skeletal muscle Anatomy 0.000 claims description 11
- 230000014509 gene expression Effects 0.000 claims description 10
- 229920001184 polypeptide Polymers 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 6
- 108091034117 Oligonucleotide Proteins 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000005013 brain tissue Anatomy 0.000 claims description 4
- 210000002808 connective tissue Anatomy 0.000 claims description 4
- 210000000981 epithelium Anatomy 0.000 claims description 4
- 210000005228 liver tissue Anatomy 0.000 claims description 4
- 210000004072 lung Anatomy 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- 210000000944 nerve tissue Anatomy 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 3
- 230000009274 differential gene expression Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000010208 microarray analysis Methods 0.000 description 2
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016165596A JP6904676B2 (ja) | 2011-06-15 | 2016-08-26 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161497476P | 2011-06-15 | 2011-06-15 | |
| US61/497,476 | 2011-06-15 | ||
| PCT/US2012/042822 WO2012174484A2 (en) | 2011-06-15 | 2012-06-15 | Identifying markers of caloric restriction and caloric restriction mimetics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016165596A Division JP6904676B2 (ja) | 2011-06-15 | 2016-08-26 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014518071A JP2014518071A (ja) | 2014-07-28 |
| JP2014518071A5 true JP2014518071A5 (enExample) | 2015-05-28 |
Family
ID=47357787
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014516069A Pending JP2014518071A (ja) | 2011-06-15 | 2012-06-15 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
| JP2016165596A Active JP6904676B2 (ja) | 2011-06-15 | 2016-08-26 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
| JP2018199144A Pending JP2019037240A (ja) | 2011-06-15 | 2018-10-23 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
| JP2021002732A Active JP7355766B2 (ja) | 2011-06-15 | 2021-01-12 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
| JP2022096412A Pending JP2022113834A (ja) | 2011-06-15 | 2022-06-15 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016165596A Active JP6904676B2 (ja) | 2011-06-15 | 2016-08-26 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
| JP2018199144A Pending JP2019037240A (ja) | 2011-06-15 | 2018-10-23 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
| JP2021002732A Active JP7355766B2 (ja) | 2011-06-15 | 2021-01-12 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
| JP2022096412A Pending JP2022113834A (ja) | 2011-06-15 | 2022-06-15 | カロリー制限およびカロリー制限模倣物の同定用マーカー |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US20130178379A1 (enExample) |
| EP (1) | EP2721155A4 (enExample) |
| JP (5) | JP2014518071A (enExample) |
| KR (1) | KR20140041710A (enExample) |
| CN (4) | CN107217051A (enExample) |
| WO (1) | WO2012174484A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11345963B2 (en) | 2018-05-07 | 2022-05-31 | Ebay Inc. | Nucleic acid taggants |
| CN113712121B (zh) * | 2021-08-31 | 2023-08-15 | 河南牧业经济学院 | 尼克酰胺在改善泌乳期奶山羊乳成分中的应用 |
| CN119700977B (zh) * | 2024-12-11 | 2025-08-22 | 山东省妇幼保健院 | Psmg4基因在制备心脏疾病治疗药物及相关诊断产品中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| EA006429B1 (ru) * | 2001-03-09 | 2005-12-29 | Сосьете Де Продюи Нестле С.А. | Композиция для предупреждения или восстановления возрастных функциональных дефицитов у млекопитающих и способ ее применения |
| CA2450126A1 (en) * | 2001-06-26 | 2003-01-09 | Wisconsin Alumni Research Foundation | Gene expression alterations underlying the retardation of aging by caloric restriction in mammals |
| CN1643162A (zh) * | 2002-03-15 | 2005-07-20 | 衣阿华州立大学研究基金公司 | 新的hmga等位基因及作为生长、脂肪量、肉质及饲料消耗比性状遗传标记的应用 |
| US20040191775A1 (en) * | 2003-03-12 | 2004-09-30 | Spindler Stephen R. | Methods of analyzing genes affected by caloric restriction or caloric restriction mimetics |
| DK1824470T3 (da) * | 2004-12-17 | 2014-08-18 | Cash Alan Brian | Fremgangsmåde til forlængelse af levetiden og forsinke starttidspunktet for alders-relateret sygdom |
| US7737158B2 (en) * | 2005-10-11 | 2010-06-15 | Washington University | Processes for regulating blood glucose in a mammal |
| BRPI0707358A2 (pt) * | 2006-02-01 | 2011-05-03 | Nestec Sa | sistema nutricional e métodos para aumentar a longevidade |
| WO2007109102A2 (en) * | 2006-03-16 | 2007-09-27 | Biomarker Pharmaceutical | Methods for interventions and testing for caloric restriction (cr) mimetics |
| EP1956096A1 (en) * | 2007-02-12 | 2008-08-13 | Université Catholique de Louvain | Method, device and kit for determining conditions related to a dysfunction of the renal proximal tubule |
| EP2644708B1 (en) * | 2008-04-30 | 2014-12-17 | Integrated Dna Technologies, Inc. | RNASE-H-based assays utilizing modified RNA monomers |
| WO2010005533A2 (en) * | 2008-06-30 | 2010-01-14 | The Johns Hopkins University | Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| WO2010104573A1 (en) * | 2009-03-11 | 2010-09-16 | Nestec S.A. | Tissue-specific aging biomarkers |
| WO2010124240A2 (en) * | 2009-04-24 | 2010-10-28 | The Regents Of The University Of California | Bin1 as a prognostic marker in cardiovascular disease |
| JP2012115374A (ja) * | 2010-11-30 | 2012-06-21 | Kao Corp | Ａｃａｃａ発現抑制方法 |
-
2012
- 2012-06-15 CN CN201710383186.7A patent/CN107217051A/zh active Pending
- 2012-06-15 EP EP12800821.6A patent/EP2721155A4/en not_active Withdrawn
- 2012-06-15 CN CN202110890757.2A patent/CN113801878A/zh active Pending
- 2012-06-15 CN CN201280039802.2A patent/CN103732745A/zh active Pending
- 2012-06-15 US US13/525,230 patent/US20130178379A1/en not_active Abandoned
- 2012-06-15 KR KR1020147000682A patent/KR20140041710A/ko not_active Withdrawn
- 2012-06-15 WO PCT/US2012/042822 patent/WO2012174484A2/en not_active Ceased
- 2012-06-15 JP JP2014516069A patent/JP2014518071A/ja active Pending
- 2012-06-15 CN CN202511512713.0A patent/CN121271860A/zh active Pending
-
2015
- 2015-08-06 US US14/820,274 patent/US20160257996A1/en active Pending
- 2015-08-06 US US14/820,245 patent/US20160186257A1/en not_active Abandoned
-
2016
- 2016-01-19 US US15/001,025 patent/US20160208330A1/en not_active Abandoned
- 2016-08-26 JP JP2016165596A patent/JP6904676B2/ja active Active
-
2018
- 2018-10-23 JP JP2018199144A patent/JP2019037240A/ja active Pending
-
2021
- 2021-01-12 JP JP2021002732A patent/JP7355766B2/ja active Active
-
2022
- 2022-06-15 JP JP2022096412A patent/JP2022113834A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mooney et al. | Comparative RNA-Seq and microarray analysis of gene expression changes in B-cell lymphomas of Canis familiaris | |
| Pedrotty et al. | Transcriptomic biomarkers of cardiovascular disease | |
| JP2012525855A5 (enExample) | ||
| JP6931125B2 (ja) | 標的遺伝子発現の数学的モデル化を使用する、ｊａｋ−ｓｔａｔ１／２細胞シグナル伝達経路活性の評価 | |
| Lacouture et al. | Development of a mismatch amplification mutation assay to correctly serotype isolates of Streptococcus suis serotypes 1, 2, 1/2, and 14 | |
| CN109661578A (zh) | 用于区分细菌和病毒感染的蛋白质特征 | |
| JP2005500834A (ja) | 敗血症または敗血症関連症候群の診断のためのバイオチップの使用 | |
| JP2012531195A5 (enExample) | ||
| JP2017529859A5 (enExample) | ||
| JP2010526298A5 (enExample) | ||
| AU2018221256A1 (en) | Serologic assay for silent brain ischemia | |
| Morbach et al. | Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study | |
| Cruz-Saavedra et al. | Enhancing trypanosomatid identification and genotyping with Oxford nanopore sequencing: Development and Validation of an 18S rRNA Amplicon-Based Method | |
| JP7355766B2 (ja) | カロリー制限およびカロリー制限模倣物の同定用マーカー | |
| JP2014518071A5 (enExample) | ||
| Ganesamoorthy et al. | Development of a multiplex ligation-dependent probe amplification assay for diagnosis and estimation of the frequency of spinocerebellar ataxia type 15 | |
| KR101604178B1 (ko) | 약물에 의한 간 손상의 예측 및 진단을 위한 바이오마커 | |
| ATE419533T1 (de) | Verfahren/präparat zur erkennung von pankreaskrebs | |
| Lambeck et al. | Comparison of sepsis-induced transcriptomic changes in a murine model to clinical blood samples identifies common response patterns | |
| Collinson | To T or not to T, that is the question | |
| Hodzic et al. | Assessment of transcriptional activity of Borrelia burgdorferi and host cytokine genes during early and late infection in a mouse model | |
| JP2018504123A5 (enExample) | ||
| JP2005500053A5 (enExample) | ||
| Haase et al. | Identification and validation of selective upregulation of ventricular myosin light chain type 2 mRNA in idiopathic dilated cardiomyopathy | |
| Liew | Expressed genome molecular signatures of heart failure. |